Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 31 October 1980:
Vol. 210. no. 4469, pp. 543 - 545
DOI: 10.1126/science.6158759

Articles

Science, Vol 210, Issue 4469, 543-545
Copyright © 1980 by American Association for the Advancement of Science


articles

Deficient natural killer cell activity in x-linked lymphoproliferative syndrome

JL Sullivan, KS Byron, FE Brewster, and DT Purtilo

The activity of natural killer cells was found to be deficient in 10 of 12 males with X-linked lymphoproliferative syndrome, a life-threatening proliferation of lymphocytes after infection by Epstein-Barr virus. The activity levels of natural killer cells from affected males were increased after treatment with interferon in vitro, but normal levels of killing were not obtained. Deficient activity of killer cells in individuals with immunodeficiency and chronic infection by Epstein-Barr virus may contribute to the development of lymphoproliferative disorders.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis and X-Linked Lymphoproliferative Disease: A Mimicker of Sepsis in the Pediatric Intensive Care Unit.
M. Mischler, G. M. Fleming, T. P. Shanley, L. Madden, J. Levine, V. Castle, A. H. Filipovich, and T. T. Cornell (2007)
Pediatrics 119, e1212-e1218
   Abstract »    Full Text »    PDF »
SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
L. Dupre, G. Andolfi, S. G. Tangye, R. Clementi, F. Locatelli, M. Arico, A. Aiuti, and M.-G. Roncarolo (2005)
Blood 105, 4383-4389
   Abstract »    Full Text »    PDF »
CAM and NK Cells.
K. Takeda and K. Okumura (2004)
Evid. Based Complement. Altern. Med. 1, 17-27
   Abstract »    Full Text »    PDF »
SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9.
M. Simarro, A. Lanyi, D. Howie, F. Poy, J. Bruggeman, M. Choi, J. Sumegi, M. J. Eck, and C. Terhorst (2004)
Int. Immunol. 16, 727-736
   Abstract »    Full Text »    PDF »
Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection.
A. Malbran, L. Belmonte, B. Ruibal-Ares, P. Bare, I. Massud, C. Parodi, M. Felippo, R. Hodinka, K. Haines, K. E. Nichols, et al. (2004)
Blood 103, 1625-1631
   Abstract »    Full Text »    PDF »
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells.
G. Ferlazzo, M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz (2002)
J. Exp. Med. 195, 343-351
   Abstract »    Full Text »    PDF »
Abnormal T Cell Receptor Signal Transduction of CD4 Th Cells in X-Linked Lymphoproliferative Syndrome.
H. Nakamura, J. Zarycki, J. L. Sullivan, and J. U. Jung (2001)
J. Immunol. 167, 2657-2665
   Abstract »    Full Text »    PDF »
Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.
M. Morra, O. Silander, S. Calpe, M. Choi, H. Oettgen, L. Myers, A. Etzioni, R. Buckley, and C. Terhorst (2001)
Blood 98, 1321-1325
   Abstract »    Full Text »    PDF »
Lymphocytic vasculitis in X-linked lymphoproliferative disease.
J. P. Dutz, L. Benoit, X. Wang, D. J. Demetrick, A. Junker, D. de Sa, and R. Tan (2001)
Blood 97, 95-100
   Abstract »    Full Text »    PDF »
Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
J. Sayos, K. B. Nguyen, C. Wu, S. E. Stepp, D. Howie, J. D. Schatzle, V. Kumar, C. A. Biron, and C. Terhorst (2000)
Int. Immunol. 12, 1749-1757
   Abstract »    Full Text »    PDF »
Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease.
L. Benoit, X. Wang, H. F. Pabst, J. Dutz, and R. Tan (2000)
J. Immunol. 165, 3549-3553
   Abstract »    Full Text »    PDF »
Epstein-Barr Virus BARF1 Protein Is Dispensable for B-Cell Transformation and Inhibits Alpha Interferon Secretion from Mononuclear Cells.
J. I. Cohen and K. Lekstrom (1999)
J. Virol. 73, 7627-7632
   Abstract »    Full Text »    PDF »
Pathological Consequences of Sequence Duplications in the Human Genome.
R. Mazzarella and D. Schlessinger (1998)
Genome Res. 8, 1007-1021
   Abstract »    Full Text »
Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte.
H. Gershenfeld and I. Weissman (1986)
Science 232, 854-858
   Abstract »    PDF »
Chronic T-Cell Lymphocytosis With Neutropenia: Its Association With Epstein-Barr Virus Infection.
H. G. Herrod, W. C. Wang, and J. L. Sullivan (1985)
Arch Pediatr Adolesc Med 139, 405-407
   Abstract »    PDF »
X-Linked Lymphoproliferative Syndrome: A New Kindred With Variable Phenotypic Expression.
R. Steinherz, Y. Levy, A. Litwin, M. Nitzan, E. Friedman, and S. Levin (1985)
Arch Pediatr Adolesc Med 139, 191-193
   Abstract »    PDF »
Delayed Onset of Infectious Mononucleosis Associated with Acquired Agammaglobulinemia and Red Cell Aplasia.
D. T. PURTILO, L. ZELKOWITZ, S. HARADA, C. D. BROOKS, T. BECHTOLD, H. LIPSCOMB, J. YETZ, and G. ROGERS (1984)
Ann Intern Med 101, 180-186
   Abstract »    PDF »
Infectious Mononucleosis in an Adult Progressing to Fatal lmmunoblastic Lymphoma.
D. R. SNYDMAN, R. A. RUDDERS, P. DAOUST, J. L. SULLIVAN, and A. S. EVANS (1982)
Ann Intern Med 96, 737-742
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)